Hochschulschrift
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production by melanoma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
XXI, 164 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Albert-Ludwigs-Universität Freiburg im Breisgau, Dissertation, 2024
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- Februar 2024
Ähnliche Objekte (12)
Increasing cure rates of solid tumors by immune checkpoint inhibitors
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells
MDM2 inhibition enhances the graft-versus-leukemia effect via TRAIL-R1/2 and MHC-II upregulation
Regulation of p53 and Mdm2 by the Tripartite-Motif-protein 25
Molecular basis for the inhibition of p53 by Mdmx and Mdm2
Pinning control for the p53-Mdm2 network dynamics regulated by p14ARF
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
Increasing cure rates of solid tumors by immune checkpoint inhibitors
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells
MDM2 inhibition enhances the graft-versus-leukemia effect via TRAIL-R1/2 and MHC-II upregulation
Regulation of p53 and Mdm2 by the Tripartite-Motif-protein 25
Molecular basis for the inhibition of p53 by Mdmx and Mdm2
Pinning control for the p53-Mdm2 network dynamics regulated by p14ARF
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2
Increasing cure rates of solid tumors by immune checkpoint inhibitors
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells
MDM2 inhibition enhances the graft-versus-leukemia effect via TRAIL-R1/2 and MHC-II upregulation
Regulation of p53 and Mdm2 by the Tripartite-Motif-protein 25
Molecular basis for the inhibition of p53 by Mdmx and Mdm2
Pinning control for the p53-Mdm2 network dynamics regulated by p14ARF